ModernMedicine Resource Center More Topics

Ocular Allergy Resource Center

Experts offer top allergy tips
Experts offer top allergy tipsWe asked industry experts for their top suggestions to colleagues on how to best manage allergy.
Applying hydrogel technology to sustained-release ocular drugsHydrogel technology enables the use of drugs that are known to be efficacious for ocular diseases and conditions when formulated as daily drops or monthly injections, into one-time or several-month dosage forms.
New therapies needed for allergy symptoms, quality of lifeHalf of patients with ocular allergies report experiencing symptoms year-round. While nearly all of them take eye drops to treat their symptoms, the majority report limited or no effect from over-the-counter drops, according to a new survey. The results suggest that new treatment approaches would improve both symptoms and quality of life.
Substance P: Dry eye and allergy’s mixed signal or missing link?Inflammation may lead to heightened peripheral sensitization and stimulation through a developing concept in which neuroimmune cross-talk causes the confounding interplay of both signs and symptoms in dry eye and allergic disease.
Topical cetirizine latest therapy to treat allergic conjunctivitisOral cetirizine is one of the most used oral medications for treatment of allergic rhinitis. In May 2017, the FDA approved the first ophthalmic formulation of the second-generation histamine-1 (H1) receptor antagonist for use in treating ocular itching associated with allergic conjunctivitis.
The latest ocular allergy treatments worth watchingProgress of ocular allergy treatment in 2017 starts with the fact that this is a mature therapeutic space, with a range of existing choices for clinicians and patients. Progression in therapies from artificial tears to antihistamines and mast cell stabilizers to topical steroids provides a suitable choice for most patients with ocular allergies.
Intracanalicular insert soothes ocular itching in allergic conjunctivitisA phase III study of dexamethasone insert, 0.4 mg (Dextenza, Ocular Therapeutix) found that the sustained-release intracanalicular insert is safe, effective, and well tolerated for treating ocular itching associated with allergic conjunctivitis.
In treating ocular allergy, ECPs reach first for combo productsIn a poll fielded to Optometry Times and Ophthalmology Times readers, we asked both ODs and MDs what they used for first-line therapy for allergy patients.
Therapy for ocular allergy patients
Surviving allergy season as a contact lens wearerDepending on where you live, spring is here—or at least on its way. It’s the time of year to thaw out along with the trees, grass, and flowers. With spring comes our promise to get ourselves into shape for the summer, and life gets busier with more outdoor activities for the whole family.